Skip to content

A study to evaluate the effect of intake of Watanabe Oyster DHMBA Jelly on the status of stress and sleep in daily life of healthy adults

A study to evaluate the effect of intake of Watanabe Oyster DHMBA Jelly on the status of stress and sleep in daily life of healthy adults - A study to evaluate the effect of intake of Watanabe Oyster DHMBA Jelly on the status of stress and sleep in daily life of healthy adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038468
Enrollment
80
Registered
2019-11-02
Start date
2019-11-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Sponsors

TTC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male and female from 20 to 65 years old. 2) Subjects who feel stress when commuting or working in daily life 3) Subjects who are judged to be highly stressed by BJSQ 4) Subjects with "Slightly High / Frequent" of "Irritation" and "Slightly High / Frequent" of "Anxiety" in BJSQ

Exclusion criteria

Exclusion criteria: 1)Subjects who routinely use food or medicine containing of DHMBA or oyster meat extract 2)Subjects who perform an act for the improvement of the fatigue, stress and the quality of the sleep at least once a week 3)Subjects who are under treatment or a history of mental illness, sleep apnea syndrome, chronic fatigue syndrome, or are strongly suspected 4)Subjects whose score for each scale of BJSQ is "High/Frequent" ("Vigor" is "Low/Infrequent") 5)Subjects who wake after sleep onset more than twice a week for nocturia, children crying at night or other reason 6)Night and day shift worker or manual laborer 7)Subjects who are have treated oral or dental care within the last one month prior to the current study or are planned to treat oral or dental care 8)Subjects who are a history of xerostomia 9)Subjects who has oral or dental problems with bleeding or develops the trouble at least once a week 10)Subjects who are have treated diseases related bowel movements and using drugs, or are regularly using commercially available constipation medicine 11)Subjects who cannot carry out the procedures of various tests to be carried out during this study 12)Subjects who are under treatment or have a history of serious diseases 13)Subjects who has a disease which may influence the outcome of the study 14)Subjects having possibilities for emerging allergy related to the study 15)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination 16)Subjects who are planned to become pregnant or are pregnant or lactating 17)Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 18)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire and other questionnaires 19)Subjects who are judged as unsuitable for the study by the investigator for other reason

Design outcomes

Primary

MeasureTime frame
The Brief Job Stress Questionnaire(BJSQ), OSA sleep inventory MA version

Secondary

MeasureTime frame
Profile of Mood States 2nd Edition-Adult Short

Countries

Japan

Contacts

Public ContactHiroyasu Shimada

TTC Co., Ltd. Clinical Research Planning Department

h.shimada@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026